US equities
|
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
NVDA
$238.90
▲+2.12%
SPCX
$171.09
▲+7.63%
MU
$1,063.96
▼-1.02%
TSLA
$378.73
▲+2.20%
WBD
$30.95
▲+0.03%
MSFT
$525.18
▲+1.48%
AAPL
$332.89
▼-0.24%
META
$741.90
▲+1.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Seer, Inc. - Class A Common Stock
(NQ:
SEER
)
2.330
+0.080 (+3.56%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Seer, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 06, 2026
Gainers Seer (NASDAQ:SEER) shares rose 32.1% to $2.14 during Monday's pre-market session. The market value of their outstanding shares is at $89.0 million. Innovative Eyewear (NASDAQ:LUCY) stock rose...
Via
Benzinga
The Radoff-JEC Group Responds to Chairman and CEO Omid Farokhzad, M.D.’s Proposal to Acquire Seer, Inc.
July 06, 2026
From
On Behalf of The Radoff-JEC Group
Via
Business Wire
Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential
July 06, 2026
From
Seer, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
July 02, 2026
Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals...
Via
Benzinga
Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
July 02, 2026
No Stockholder Action Required at This Time
From
Seer, Inc.
Via
GlobeNewswire
Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics
July 01, 2026
Seer's particle-based proteomics IP withstands challenges in both Europe and the United States
From
Seer, Inc.
Via
GlobeNewswire
The Radoff-JEC Group Releases Presentation Highlighting Why Seer, Inc. Stockholders Should Vote for Boardroom Change
June 29, 2026
From
On Behalf of The Radoff-JEC Group
Via
Business Wire
The Radoff-JEC Group Urges Seer, Inc. Stockholders to Vote for Boardroom Change Today
June 24, 2026
From
On Behalf of The Radoff-JEC Group
Via
Business Wire
Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening
June 22, 2026
Findings from more than 5,500 plasma samples demonstrate the feasibility of combining deep plasma proteomics generated by the Proteograph Product Suite with ID-Free AI approaches across ten major...
From
Seer, Inc.
Via
GlobeNewswire
The Radoff-JEC Group Highlights Seer Inc.’s and Chairman and CEO Omid Farokhzad, M.D.’s History of Value Destruction
June 15, 2026
From
On Behalf of The Radoff-JEC Group
Via
Business Wire
Seer Board of Directors Issues Letter to Shareholders Highlighting the Company’s Significant Scientific Progress and Addressing Radoff and Torok’s Short-Sighted Campaign
June 15, 2026
Urges Stockholders to Vote “FOR” ONLY Seer’s Director Nominees on the BLUE Proxy Card
From
Seer, Inc.
Via
GlobeNewswire
Seer Files Definitive Proxy Materials and Mails Letter to Stockholders
June 03, 2026
From
Seer, Inc.
Via
GlobeNewswire
Seer Files ITC Complaint Against Nanomics
May 29, 2026
Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations
From
Seer, Inc.
Via
GlobeNewswire
The Radoff-JEC Group Calls on Seer Inc. and Its Advisors to Reevaluate Its Premium Acquisition Proposal in the Best Interests of All Stockholders
May 27, 2026
From
On Behalf of The Radoff-JEC Group
Via
Business Wire
Seer to Showcase AI-Driven Multi-Cancer Screening Approach and Next-Generation Proteomics Capabilities at ASMS 2026
May 26, 2026
Drs. Sang-Won Lee and Jaewoo Kang to share early insights from Seer's 20,000-sample collaboration with Korea University in breakfast symposium on AI-driven multi-cancer screening
From
Seer, Inc.
Via
GlobeNewswire
Seer Board of Directors Unanimously Rejects Further Revised Unsolicited Proposal from Radoff-JEC Group
May 21, 2026
From
Seer, Inc.
Via
GlobeNewswire
Seer (SEER) Q1 2026 Earnings Call Transcript
↗
May 14, 2026
Seer (SEER) Q1 2026 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Intellectual Property
The Radoff-JEC Group Submits its Third Non-Binding Proposal to Acquire Seer, Inc.
May 14, 2026
From
On Behalf of The Radoff-JEC Group
Via
Business Wire
Seer Q1 Earnings Call Highlights
↗
May 14, 2026
Seer (NASDAQ:SEER) reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, with management pointing to population-scale proteomics studies, an expanding publication base and...
Via
MarketBeat
Topics
Earnings
Seer Reports First Quarter 2026 Financial Results and Reaffirms Full Year 2026 Outlook
May 13, 2026
From
Seer, Inc.
Via
GlobeNewswire
Seer Files Patent Infringement Lawsuit Against Nanomics
May 13, 2026
From
Seer, Inc.
Via
GlobeNewswire
Seer Announces Appointment of Anthony Bazarko as Chief Commercial Officer
May 04, 2026
From
Seer, Inc.
Via
GlobeNewswire
Seer to Report First Quarter 2026 Financial Results on May 13, 2026
April 29, 2026
From
Seer, Inc.
Via
GlobeNewswire
The Radoff-JEC Group Responds to Seer, Inc.’s Rejection of April 24th Acquisition Proposal
April 29, 2026
From
On Behalf of The Radoff-JEC Group
Via
Business Wire
Seer Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Radoff-JEC Group
April 27, 2026
Board Determines Proposal Significantly Undervalues Seer and Is Not in the Best Interests of Stockholders
From
Seer, Inc.
Via
GlobeNewswire
The Radoff-JEC Group Submits Improved Non-Binding Proposal to Acquire Seer, Inc.
April 24, 2026
From
On Behalf of The Radoff-JEC Group
Via
Business Wire
Seer Confirms Receipt of Unsolicited Proposal and Director Candidate Nominations from Radoff-JEC Group
April 13, 2026
No Stockholder Action Required at This Time
From
Seer, Inc.
Via
GlobeNewswire
Seer Shares Jump On Takeover Proposal
↗
April 13, 2026
Seer, Inc. (NASDAQ:SEER) shares are trading higher Monday after the company announced that the Radoff-JEC Group submitted a non-binding proposal to acquire the company.
Via
Benzinga
The Radoff-JEC Group Submits Non-Binding Proposal to Acquire Seer, Inc.
April 13, 2026
From
On Behalf of The Radoff-JEC Group
Via
Business Wire
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples
April 09, 2026
Seer’s Proteograph will be used to generate enhanced proteomic insights in one of the world’s largest multi-omic health studies
From
Seer, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
